Biotechnology
Most Popular Under $25
100 Most Popular

Catalyst Pharmaceuticals

$4.25
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.20 (4.81%) As of 12:30 PM EDT today
+$0.20 (4.81%) Today

Why Robinhood?

You can buy or sell CPRX and other stocks, options, ETFs, and crypto commission-free!

About CPRX

Catalyst Pharmaceuticals, Inc. Common Stock, also called Catalyst Pharmaceuticals, is a biopharmaceutical company, which engages in the development and commercialization of therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases, including Lambert-Eaton myasthenic syndrome (LEMS), congenital myasthenic syndromes (CMS), MuSK antibody positive myasthenia gravis, spinal muscular atrophy (SMA) type 3, and infantile spasmsThe company was founded Huckel E. Read More Hubert in January 2002 and is headquartered in Coral Gables, FL.

Employees
51
Headquarters
Coral Gables, Florida
Founded
2002
Market Cap
416.36M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
830.45K
High Today
$4.26
Low Today
$4.01
Open Price
$4.06
Volume
424.41K
52 Week High
$6.16
52 Week Low
$1.85

Collections

Biotechnology
Most Popular Under $25
100 Most Popular
Technology
Health
Pharmaceutical
Biopharmaceutical
US

CPRX Earnings

-$0.14
-$0.10
-$0.05
-$0.01
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 7, Pre-Market

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.